Qualitative Assay Kit for 7 IDH1 Genomic Mutations and 5 IDH2 Genomic Mutations - Vietnam Registration 2300551ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Qualitative Assay Kit for 7 IDH1 Genomic Mutations and 5 IDH2 Genomic Mutations in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2300551ĐKLH/BYT-HTTB and manufactured by Veracyte SAS.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2300551ĐKLH/BYT-HTTB
000.00.04.G18-201026-0013
therascreen® IDH1/2 RGQ PCR Kit
873011
Technical Details
Therascreen IDH1/2 RGQ PCR Kit is an in vitro diagnostic test based on PCR technology, designed to qualitatively detect 7 IDH1 gene mutations and 5 IDH2 gene mutations, and to directly determine the 3 primary mutations in the DNA extracted from formalin-fixed human brain tissue (FFPE). The Therascreen IDH1/2 RGQ PCR Kit is used to assist in the classification of glioma
Dates and Status
Jun 20, 2023